Table 1 Hepatic arterial flow, portal venous flow, and microvascular perfusion in the control and cilostazol group on POD 0, POD 1, POD 3, and POD 7.

From: Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model

 

Hepatic artery [µL/min/g BW]

Portal vein [µL/min/g BW]

Microvascular perfusion [aU]

POD 0

 Control

0.8 ± 0.2

26.8 ± 4.2

437.4 ± 55.3

 Cilostazol

1.2 ± 0.3

41.0 ± 5.1

368.3 ± 20.8

POD 1

 Control

0.7 ± 0.1

56.6 ± 3.1

508.6 ± 25.2

 Cilostazol

0.8 ± 0.1

37.3 ± 5.7

319.5 ± 36.2

POD 3

 Control

1.1 ± 0.1

42.8 ± 5.0

344.4 ± 32.7

 Cilostazol

0.8 ± 0.1*

41.9 ± 3.6

416.7 ± 34.1

POD 7

 Control

0.6 ± 0.1

27.5 ± 3.4

365.1 ± 25.9

 Cilostazol

1.5 ± 0.1

43.1 ± 4.9

357.3 ± 50.4

  1. Mean ± SEM, * p < 0.05 vs. control.
Back to article page